| (1R,2S,3R)-Aprepitant |
|
|
|
|
| (D-Arg1,D-Pro2,D-Phe7,D-His9)-Substance P |
|
|
|
|
| (D-Arg1,D-Pro2,D-Trp7,9,L-Leu11)-Substance P |
|
|
|
|
| (D-Arg1,D-Pro2,D-Trp7,9,L-Leu11)-Substance P acetate |
|
|
|
|
| (D-Pro2,D-Trp6,8,Nle10)-Neurokinin B |
|
|
|
|
| (R)-Casopitant |
|
|
|
98.60% |
| (R)-Nolpitantium |
|
|
|
|
| (Rac)-LM11A-31 |
|
|
|
|
| (Trp7,β-Ala8)-Neurokinin A (4-10) |
|
|
|
|
| (β-Ala8)-Neurokinin A (4-10) |
|
|
|
98.49% |
| [Asp5,6,Me-Phe8] Substance P (5-11) |
|
|
|
|
| [bAla8]-Neurokinin A(4-10) |
|
|
|
96.98% |
| [D-Pro2,D-Phe7,D-Trp9] Substance P |
|
|
|
|
| [D-Pro2,D-Trp7,9] Substance P |
|
|
|
|
| [D-Pro2] Spantide I TFA |
|
|
|
99.15% |
| [D-Pro4,D-Trp7,9,10] Substance P (4-11) |
|
|
|
|
| [D-Pro4,D-Trp7,9,Nle11] Substance P (4-11) |
|
|
|
|
| [D-Pro4,D-Trp7,9] Substance P (4-11) |
|
|
|
|
| [D-Trp2,7,9] Substance P |
|
|
|
|
| [DAla4] Substance P (4-11) |
|
|
|
|
| [Dehydro-Pro4] Substance P (4-11) |
|
|
|
|
| [Glp5,(Me)Phe8,Sar9] Substance P (5-11) |
|
|
|
99.61% |
| [Glp5,Sar9] Substance P (5-11) |
|
|
|
|
| [Glp5] Substance P (5-11) |
|
|
|
|
| [Glp6] Substance P (6-11) |
|
|
|
|
| [Gly11] Substance P |
|
|
|
|
| [His11]Substance P |
|
|
|
98.97% |
| [Lys5,MeLeu9,Nle10]-NKA(4-10) |
|
|
|
|
| [Lys5,MeLeu9,Nle10]-NKA(4-10) TFA |
|
|
|
|
| [Lys5,MeLeu9,Nle10]Neurokinin A(4-10) |
|
|
|
99.89% |
| [Lys5,Tyr6,mLeu9,Nle10]-Neurokinin A (4-10) |
|
|
|
|
| [MePhe7]-Neurokinin B |
|
|
|
98.76% |
| [MePhe8,Sar9] Substance P |
|
|
|
|
| [Nle11]-Substance P |
|
|
|
|
| [Pro9]-Substance P |
|
|
|
|
| [S5K, F6Y, L9mL, M10Mox] neurokinin A (4-10) |
|
|
|
98.14% |
| [Sar4] Substance P (4-11) |
|
|
|
|
| [Sar9,Met(O2)11]-Substance P |
|
|
|
98.65% |
| [Sar9,Met(O2)11]-Substance P TFA |
|
|
|
98.58% |
| [Sar9] Substance P |
|
|
|
98.14% |
| [Tyr6,D-Phe7,D-His9]-Substance P (6-11) |
|
|
|
|
| [Tyr8,Nle11] Substance P |
|
|
|
|
| Acetylaszonalenin |
|
|
|
|
| Anti-Mouse NK1.1 Antibody (PK136) |
|
|
|
98.57% |
| Aprepitant-13C2,d2 (Major) |
|
|
|
|
| ASN-1377642 |
|
|
|
|
| AWL 60 |
|
|
|
|
| Befetupitant |
|
|
|
|
| Benzomalvin A |
|
|
|
|
| Benzomalvin B |
|
|
|
|
| Benzomalvin C |
|
|
|
|
| Biotin-Neurokinin A |
|
|
|
|
| Biotin-Substance P |
|
|
|
99.66% |
| Bz-Dab(NBD)-AwFpP-Nle-NH2 |
|
|
|
|
| C14TKL-1 |
|
|
|
|
| C14TKL-1 acetate |
|
|
|
|
| Casopitant |
|
|
|
|
| Casopitant mesylate |
|
|
|
99.08% |
| CGP-49823 |
|
|
|
|
| CJ-17493 |
|
|
|
|
| CP 122721 |
|
|
|
|
| CP 122721 hydrochloride |
|
|
|
|
| CP-96,345 |
|
|
|
99.9% |
| CP-99994 |
|
|
|
|
| CP-99994 hydrochloride |
|
|
|
|
| CS-003 Free base |
|
|
|
|
| Dapitant |
|
|
|
|
| Dazodeunetant |
|
|
|
|
| Dilopetine citrate |
|
|
|
|
| Ditryptophenaline |
|
|
|
|
| DNK-333 |
|
|
|
|
| EB1002 |
|
|
|
99.98% |
| Eledoisin Related Peptide |
|
|
|
99.55% |
| Elinzanetant |
|
|
|
99.82% |
| Elinzanetant-d3 |
|
|
|
|
| Esmolol |
|
|
|
|
| Ezlopitant |
|
|
|
|
| Fezolinetant |
|
|
|
99.19% |
| Fezolinetant-d4 |
|
|
|
|
| FK888 |
|
|
|
|
| Fosnetupitant |
|
|
|
|
| Fosnetupitant chloride monohydrochloride |
|
|
|
99.70% |
| Fosnetupitant-d6 dihydrochloride |
|
|
|
|
| Fosrolapitant |
|
|
|
|
| FR 113680 |
|
|
|
|
| Gly-Leu-Met-NH2 |
|
|
|
99.76% |
| GR 159897 |
|
|
|
99.6% |
| GR 64349 |
|
|
|
99.12% |
| GR 64349 acetate |
|
|
|
|
| GR 64349 TFA |
|
|
|
|
| GR 82334 |
|
|
|
|
| GR 83074 |
|
|
|
|
| GR 87389 |
|
|
|
|
| GR 94800 |
|
|
|
99.42% |
| GR 94800 TFA |
|
|
|
|
| GR-73632 |
|
|
|
99.89% |
| GR203040 |
|
|
|
|
| GSK172981 |
|
|
|
|
| GSK256471 |
|
|
|
|
| H-Glu(OtBu)-OtBu hydrochloride |
|
|
|
98.0% |
| Hemokinin 1 (mouse) |
|
|
|
98.38% |
| Hemokinin 1, human |
|
|
|
98.11% |
| Hemokinin 1, human TFA |
|
|
|
|
| Ibodutant |
|
|
|
|
| Imnopitant |
|
|
|
|
| Imnopitant dihydrochloride |
|
|
|
|
| L 363851 |
|
|
|
|
| L 743310 |
|
|
|
|
| L-659837 |
|
|
|
|
| L-659874 |
|
|
|
|
| L-659877 |
|
|
|
|
| L-703606 |
|
|
|
|
| L-703606 oxalate |
|
|
|
|
| L-703606 oxalate hydrate |
|
|
|
99.4% |
| L-732138 |
|
|
|
99.9% |
| L-733060 |
|
|
|
|
| L-733060 hydrochloride |
|
|
|
99.9% |
| L-741671 |
|
|
|
|
| L-760735 |
|
|
|
99.9% |
| Lanepitant |
|
|
|
|
| Lanepitant dihydrochloride |
|
|
|
|
| Leucyl-phenylalanine amide |
|
|
|
|
| LM11A-31 |
|
|
|
99.88% |
| Maropitant citrate |
|
|
|
|
| Maropitant citrate hydrate |
|
|
|
99.19% |
| MDL 105212A |
|
|
|
|
| MDL 29913 |
|
|
|
|
| MEDI-1912 |
|
|
|
|
| MEN 10207 |
|
|
|
99.80% |
| MEN 10207 acetate |
|
|
|
|
| MEN 10208 |
|
|
|
|
| Men 10376 |
|
|
|
|
| Men 10376 TFA |
|
|
|
99.67% |
| MEN11467 |
|
|
|
|
| MLGFFQQPKPR-NH2 |
|
|
|
|
| Monohydroxy Netupitant-d6 |
|
|
|
|
| N-Acetyl-L-tryptophan |
|
|
|
99.82% |
| N-Acetyl-L-tryptophan-d3 |
|
|
|
|
| Netupitant metabolite Monohydroxy Netupitant |
|
|
|
|
| Neurokinin A(4-10) TFA |
|
|
|
98.05% |
| Neurokinin antagonist 1 |
|
|
|
|
| Neurokinin Receptor (393-407), rat |
|
|
|
|
| Neuropeptide K (human, porcine, rat) |
|
|
|
|
| NK1 receptor antagonist 2 |
|
|
|
97.98% |
| NK3R antagonist-1 |
|
|
|
|
| NK3R-IN-1 |
|
|
|
|
| NK3R-IN-2 |
|
|
|
|
| NKP608 |
|
|
|
99.88% |
| Orvepitant |
|
|
|
|
| Orvepitant maleate |
|
|
|
99.99% |
| Osanetant |
|
|
|
98.11% |
| Osanetant monohydrochloride |
|
|
|
|
| Pavinetant |
|
|
|
99.63% |
| PD-161182 |
|
|
|
|
| Phenylalanylphenylalanylamide |
|
|
|
|
| Phyllomedusin |
|
|
|
|
| Physalaemin |
|
|
|
|
| Substance P |
|
|
|
99.52% |
| QWF Peptide |
|
|
|
98.51% |
| R116031 |
|
|
|
|
| rac-Vofopitant-d3 |
|
|
|
|
| Ranakinin |
|
|
|
|
| RO4583298 |
|
|
|
|
| RO5328673 |
|
|
|
|
| Rolapitant hydrochloride |
|
|
|
|
| Rolapitant hydrochloride hydrate |
|
|
|
98.36% |
| RP 67580 |
|
|
|
99.05% |
| S 16474 |
|
|
|
|
| SB 218795 |
|
|
|
99.86% |
| SB 218795 (Standard) |
|
|
|
|
| SB 235375 |
|
|
|
98.13% |
| SB 414240 |
|
|
|
|
| SB-222200 |
|
|
|
99.85% |
| SCH 206272 |
|
|
|
|
| SCH 60057 |
|
|
|
|
| SCH 900978 |
|
|
|
|
| SCH-720881 |
|
|
|
|
| Scyliorhinin I |
|
|
|
|
| Scyliorhinin II |
|
|
|
|
| SDZ NKT 343 |
|
|
|
|
| Senktide |
|
|
|
99.91% |
| Senktide TFA |
|
|
|
|
| Septide |
|
|
|
98.97% |
| Serlopitant |
|
|
|
|
| SLV-317 |
|
|
|
|
| SLV-317 free base |
|
|
|
|
| Spantide I |
|
|
|
99.64% |
| Spantide I TFA |
|
|
|
99.32% |
| Spantide II |
|
|
|
99.47% |
| SR140333B |
|
|
|
|
| SSR 146977 |
|
|
|
|
| SSR 146977 hydrochloride |
|
|
|
|
| SSR-241586 |
|
|
|
|
| Substance P (1-9) |
|
|
|
99.48% |
| Substance P (2-11) |
|
|
|
|
| Substance P (3-11) |
|
|
|
|
| Substance P (3-11) acetate |
|
|
|
|
| Substance P (4-11) |
|
|
|
|
| Substance P (5-11) |
|
|
|
|
| Substance P (5-11) TFA |
|
|
|
97.39% |
| Substance P (6-11) |
|
|
|
|
| Substance P (7-11) |
|
|
|
99.08% |
| Substance P (alligator) |
|
|
|
|
| Substance P Receptor Antagonist 1 |
|
|
|
99.42% |
| Substance P TFA |
|
|
|
99.34% |
| Substance P(1-4) |
|
|
|
|
| Substance P(1-7) |
|
|
|
|
| Substance P(1-7) TFA |
|
|
|
99.14% |
| Substance P, Free Acid |
|
|
|
98.07% |
| Substance P, free acid TFA |
|
|
|
|
| Substance P-Gly-Lys-Arg |
|
|
|
|
| TAC 363 |
|
|
|
|
| Tachykinin angatonist 1 |
|
|
|
|
| TAK-637 |
|
|
|
|
| Telmapitant |
|
|
|
|
| TKA-731 |
|
|
|
|
| Tradipitant |
|
|
|
99.95% |
| Tyr0-Neurokinin A |
|
|
|
|
| Tyr0-Neurokinin B |
|
|
|
|
| UK-224671 |
|
|
|
|
| Uperolein |
|
|
|
|
| Vapreotide diacetate |
|
|
|
|
| Vestipitant |
|
|
|
|
| Vestipitant mesylate |
|
|
|
|
| Vofopitant |
|
|
|
99.82% |
| Vofopitant dihydrochloride |
|
|
|
99.56% |
| WIN 51708 |
|
|
|
99.70% |
| WIN 62,577 |
|
|
|
|
| WIN 62577 |
|
|
|
|
| WIN 66306 |
|
|
|
99.2% |
| WIN-64821 |
|
|
|
|
| WS9326A |
|
|
|
|
| Y1 receptor antagonist 1 |
|
|
|
95.03% |
| Y1 receptor antagonist 1 formic |
|
|
|
99.84% |
| YM-44778 |
|
|
|
|
| YM-49598 iodide |
|
|
|
|
| Zalsenertant tetraxetan |
|
|
|
|
| ZD6021 |
|
|
|
|
| ZM 253270 |
|
|
|
|
| γ-Neuropeptide (rabbit) |
|
|
|
99.99% |
| Talnetant |
|
|
|
99.38% |
| Vapreotide |
|
|
|
99.72% |
| Eprazinone |
|
|
|
|
| Octahydroisoindole |
|
|
|
99.09% |
| Netupitant-d6 |
|
|
|
99.56% |
| Netupitant |
|
|
|
99.90% |
| Saredutant |
|
|
|
98.09% |
| Talnetant hydrochloride |
|
|
|
|
| Eprazinone dihydrochloride |
|
|
|
99.05% |
| Esmolol hydrochloride |
|
|
|
99.69% |
| Neurokinin A |
|
|
|
99.86% |
| Neurokinin A(4-10) |
|
|
|
|
| Neurokinin A TFA |
|
|
|
99.56% |
| Neurokinin B |
|
|
|
98.48% |
| Neurokinin B TFA |
|
|
|
99.36% |
| Fosaprepitant |
|
|
|
|
| Fosaprepitant dimeglumine |
|
|
|
98.42% |
| Fosaprepitant-d4 dimeglumine |
|
|
|
|
| Eledoisin |
|
|
|
99.06% |
| Rolapitant |
|
|
|
99.89% |
| Kassinin |
|
|
|
|
| Nolpitantium |
|
|
|
|
| Vapreotide acetate |
|
|
|
98.16% |
| Aprepitant |
|
|
|
99.82% |
| Maropitant-13C,d3 |
|
|
|
|
| Maropitant-d3 |
|
|
|
|
| Maropitant |
|
|
|
99.39% |